Neurogene stops Batten gene therapy after FDA denies request, dealing double dose of bad news Read more →
Incyte's $750M buyout rocked by pause on key trial, asset cull Read more →
Nearing potential FDA approval, BridgeBio shows additional positive data on ATTR-CM candidate acoramidis Read more →
Talent to power Life Sciences
Tech talent for Life Sciences
« All Events
An agenda-free networking evening which provides opportunities for key people from companies working in or with the life sciences sector to network and socialise with their peers in an informal setting over a drink or two.